Leaderboard Ad

Two Guest Lectures Scheduled for Monday

Two Guest Lectures, the Cotton-Fitton Endowed Lecture in Pediatric Otolaryngology and the Eugene N. Myers, MD International Lecture on Head and Neck Cancer, will be presented Monday.

Pediatric Otolaryngology: The Value Proposition of Subspecialty Training

Marci M. Lesperance, MD

Marci M. Lesperance, MD

Marci M. Lesperance, MD, Professor of Otolaryngology-Head and Neck Surgery at the University of Michigan Health System, Ann Arbor, will present the Cotton-Fitton Endowed Lecture in Pediatric Otolaryngology from 9:45 am-10:45 am Monday in Ballroom C4.

Surgeons today are increasingly asked to define how they provide value, but how is that value ascertained? Dr. Lesperance will address this issue in her lecture.

“Wikipedia defines the value proposition as ‘a promise of value to be delivered and acknowledged, and a belief from the customer that value will be delivered and experienced.’ Value can be measured according to the outcomes and benefits realized in proportion to the resources required. Because value also relates to the education and training of surgeons, I will discuss clinical cases that illustrate the scope of pediatric otolaryngology today,” she said.

Dr. Lesperance said she would describe the evolution of pediatric otolaryngology as a subspecialty, with a focus on the current state of fellowship training. Recent surveys indicate that more than half of otolaryngology residents plan to pursue fellowship training, with pediatric otolaryngology a frequent choice.

“Pediatric otolaryngology is a field that has grown in recent years with advances in health care,” she said, pointing to advances in medicine that allow children with life-threatening illnesses to survive into adulthood, as well as the growing number of pediatric hospitals. “Pediatric otolaryngology must continue to train the next generation of surgeons to provide complex pediatric otolaryngological care, while maintaining the excellence of training for otolaryngology residents to prepare them for diverse future careers.”

Care and Rehabilitation of Patients Treated for Advanced Laryngeal Cancer


Frans J.M. Hilgers, MD, PhD

Frans J.M. Hilgers, MD, PhD, Chairman Emeritus of Head and Neck Oncology and Surgery at the Netherlands Cancer Institute, Amsterdam, will present the Eugene N. Myers, MD International Lecture on Head and Neck Cancer from 2:15 pm-3:15 pm Monday in Ballroom C4.

In this 25th anniversary lecture, Dr. Hilgers will examine the changing landscape of treatment for advanced larynx cancer. He will examine the consequences for care and rehabilitation in light of therapy evolving from organ sacrificing to organ preserving.

“Rehabilitation has moved from focusing on the aftermath of the loss of one’s voice box, lung-powered voice, and sense of smell to concentrate on functional issues caused by the compromised larynx and pharynx after chemoradiotherapy, which is especially seen by the presence of acute and chronic dysphagia,” said Dr. Hilgers, adding that he would touch on the long overdue research needed to develop function and organ preservation protocols.

Total laryngectomy remains indispensable as a primary treatment modality for advanced (T4) larynx cancer, and for the management of recurrent disease and/or debilitating laryngeal dysfunction after prior nonsurgical treatment.

Thus, post-laryngectomy rehabilitation remains an essential theme for today’s laryngeal cancer care and rehabilitation, he said, stressing that a lifelong multidisciplinary team commitment is needed.

“The involvement of the head and neck surgeon should not stop at the surgical voice restoration procedure itself, but it should be continued long after, not leaving the allied health professional to struggle too long alone with an occasional unavoidable problem, as now sometimes is the case,” Dr. Hilgers said.

In addition to looking at the pathophysiology of the post-laryngectomy voice, breathing, and olfaction, and their current rehabilitation options, he will give special attention to developments in clinical research and medical device technology.

“These developments in most cases still enable reliable restoration of pulmonary-driven speech and compensation for lost upper respiratory tract functions, despite increasing surgical challenges,” he said.